Anthem Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	199.84	2,729	1,714	1,839	3,422	3,418
Short-Term Investments	6,847	-	-	-	4,929	2,691
Trading Asset Securities	-	6,656	3,123	4,591	-	-
Cash & Short-Term Investments	7,047	9,385	4,837	6,429	8,351	6,109
Cash Growth	-31.68%	94.01%	-24.76%	-23.01%	36.70%	148.94%
Accounts Receivable	5,272	5,906	4,504	4,904	2,741	3,262
Other Receivables	-	29.15	95.15	1.96	12.15	73.23
Receivables	5,272	5,935	4,599	4,906	2,753	3,335
Inventory	1,886	1,245	3,404	2,113	1,294	582.3
Prepaid Expenses	-	45.71	2.14	31.67	19.43	25.04
Other Current Assets	4,605	1,421	2,039	1,335	814.18	881.44
Total Current Assets	18,810	18,031	14,882	14,816	13,232	10,933
Property, Plant & Equipment	10,763	10,471	9,981	8,210	6,039	4,759
Long-Term Investments	5,765	3,419	1,208	125.53	61.6	36.96
Other Intangible Assets	9.63	4.41	38.71	62.43	90.89	68.99
Long-Term Accounts Receivable	31.08	31.08	31.12	31.08	31.08	31.12
Long-Term Deferred Tax Assets	388.97	273.22	179.47	413.95	249.08	159.38
Other Long-Term Assets	1,013	1,990	1,701	249.73	370.15	127.81
Total Assets	36,864	34,293	28,076	23,981	20,145	16,189

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	1,652	752.17	1,101	1,007	719.41	648.41
Accrued Expenses	230.53	606.66	252.29	308.02	249.82	245.63
Short-Term Debt	-	43.6	429.52	817.96	87.46	274.93
Current Portion of Long-Term Debt	189.74	189.74	189.74	390.71	201.3	11.5
Current Portion of Leases	13.58	19.73	15.06	16.85	3.22	21.22
Current Income Taxes Payable	292.01	373.05	230.27	64.11	58.83	193.89
Current Unearned Revenue	-	-	-	-	3.85	-
Other Current Liabilities	1,026	1,272	1,045	781.21	314.81	866.29
Total Current Liabilities	3,404	3,257	3,262	3,386	1,639	2,262
Long-Term Debt	196.85	277.34	470.28	1,117	961.88	245.8
Long-Term Leases	11.52	8.83	28.56	43.06	7.64	24.39
Long-Term Unearned Revenue	5.82	7	9.34	11.69	14.18	16.64
Pension & Post-Retirement Benefits	-	163.03	43.87	39.78	33.6	31.99
Other Long-Term Liabilities	436.08	154.4	162.81	137.21	81.89	57.99
Total Liabilities	4,054	3,868	3,977	4,735	2,738	2,639

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	1,127	1,123	1,118	1,118	1,141	87.76
Additional Paid-In Capital	-	1,512	1,252	1,252	2,719	2,700
Retained Earnings	-	27,479	21,392	16,879	13,570	10,726
Comprehensive Income & Other	31,683	311	336.79	-2.72	-23.05	35.82
Shareholders' Equity	32,810	30,425	24,099	19,247	17,407	13,550
Total Liabilities & Equity	36,864	34,293	28,076	23,981	20,145	16,189

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	411.69	539.24	1,133	2,385	1,262	577.84
Net Cash (Debt)	6,635	8,846	3,704	4,044	7,090	5,531
Net Cash Growth	-27.99%	138.80%	-8.41%	-42.96%	28.17%	286.71%
Net Cash Per Share	11.69	15.59	6.60	7.13	12.43	9.70
Filing Date Shares Outstanding	563.9	561.71	561.61	559.08	570.49	570.46
Total Common Shares Outstanding	563.9	561.71	559.08	559.08	570.49	570.46
Working Capital	15,406	14,774	11,619	11,429	11,593	8,671
Book Value Per Share	58.18	54.16	43.10	34.43	30.51	23.75
Tangible Book Value	32,800	30,421	24,060	19,184	17,316	13,481
Tangible Book Value Per Share	58.17	54.16	43.04	34.31	30.35	23.63
Land	-	836.13	836.13	836.13	836.13	836.13
Buildings	-	3,432	3,239	2,012	1,579	1,304
Machinery	-	10,467	8,595	6,761	6,137	4,632
Construction In Progress	-	2,643	2,969	3,447	1,641	1,538